Synopsis of recent research by authors named "Dongyang Ding"
Dongyang Ding's recent research focuses primarily on hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC), exploring novel biomarkers and therapeutic targets to improve patient prognosis and treatment outcomes.
Key findings include the identification of collagen and thrombospondin-1 as potential biomarkers for HCC and ICC, as well as the role of IL-17a and FAP in promoting liver tumorigenesis through the STAT3 signaling pathway.
Additionally, Ding's work on metabolomics indicates that metabolic profiling can classify different HCC subtypes, which could lead to more personalized treatment strategies and enhance early diagnosis efforts.
